{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T10:31:52Z","timestamp":1793442712764,"version":"4.5.0"},"reference-count":133,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T00:00:00Z","timestamp":1789862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005075","name":"UMCG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005075","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"Horizon 2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["101202066"],"award-info":[{"award-number":["101202066"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jconrel.2026.115357","type":"journal-article","created":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:24:55Z","timestamp":1789914295000},"page":"115357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PB","title":["A design framework for skin-targeted RNA nanomedicines: spatial reprogramming of immune memory in psoriasis"],"prefix":"10.1016","volume":"399","author":[{"given":"Graziela Scheuer","family":"Gomes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi\u00e9cla Osvaldt","family":"Rosales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordano Cichelero","family":"Facchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiza Abrah\u00e3o","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Serena","family":"Longhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9lder A.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.115357_bb0005","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.2147\/DDDT.S447780","article-title":"RNA-based antipsoriatic gene therapy: an updated review focusing on evidence from animal models","volume":"18","author":"Lin","year":"2024","journal-title":"Drug Des. Dev. Ther."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115357_bb0010","first-page":"2397","article-title":"Topical delivery of biologics and nucleic acids in psoriasis: nanocarrier approaches","volume":"16","author":"Wu","year":"2024","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115357_bb0015","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jid.2019.06.146","article-title":"Targeting the IL-17 receptor using liposomal spherical nucleic acids as topical therapy for psoriasis","volume":"140","author":"Liu","year":"2020","journal-title":"J. Invest. Dermatol."},{"issue":"19","key":"10.1016\/j.jconrel.2026.115357_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910841","article-title":"Skin barrier dysregulation in psoriasis","volume":"22","author":"Orsmond","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.jconrel.2026.115357_bb0025","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1007\/s13555-025-01494-z","article-title":"Comparative effectiveness and durability of biologics through 24 months for patients with moderate-to-severe psoriasis: results from the International, Observational Psoriasis Study of Health Outcomes (PSoHO)","volume":"15","author":"Pinter","year":"2025","journal-title":"Dermatol. Ther."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115357_bb0030","doi-asserted-by":"crossref","first-page":"10","DOI":"10.53388\/BMEC2026010","article-title":"A review of advancements in the management and treatment of psoriasis","volume":"5","author":"Wilson","year":"2025","journal-title":"Biomed. Eng. Commun."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115357_bb0035","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jaci.2024.05.008","article-title":"Inflammatory memory in psoriasis: from remission to recurrence","volume":"154","author":"Francis","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2026.115357_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115021","article-title":"Psoriasis unveiled: the cellular ballet, molecular symphony, and genetic puzzle","volume":"161","author":"Sharma","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2026.115357_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1643418","article-title":"Skin immune microenvironment in psoriasis: from bench to bedside","volume":"16","author":"Yao","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115357_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2025.102674","article-title":"The epidermal immune microenvironment plays a central role in the pathogenesis of psoriasis","volume":"97","author":"Zhou","year":"2025","journal-title":"Curr. Opin. Immunol."},{"issue":"269","key":"10.1016\/j.jconrel.2026.115357_bb0055","doi-asserted-by":"crossref","first-page":"269rv1","DOI":"10.1126\/scitranslmed.3010641","article-title":"Resident memory T cells in human health and disease","volume":"7","author":"Clark","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.115357_bb0060","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-67475-0","article-title":"Sustained skin clearance and lesional CD8+ tissue-resident memory T cell depletion with high-dose risankizumab in patients with moderate-to-severe plaque psoriasis: results from the Phase 2 KNOCKOUT trial","author":"Blauvelt","year":"2025","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115357_bb0065","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12016-024-08991-7","article-title":"The immunology of psoriasis \u2014 current concepts in pathogenesis","volume":"66","author":"Sieminska","year":"2024","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115357_bb0070","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3390\/ijms23020669","article-title":"The brain-skin axis in psoriasis \u2014 psychological, psychiatric, hormonal, and dermatological aspects","volume":"23","author":"Marek-Jozefowicz","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115357_bb0075","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115357_bb0080","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1186\/s12951-022-01651-y","article-title":"Advances in the modulation of ROS and transdermal administration for anti-psoriatic nanotherapies","volume":"20","author":"Xu","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115357_bb0085","doi-asserted-by":"crossref","DOI":"10.1172\/JCI169450","article-title":"Targeting immune cell trafficking and vascular endothelial cells in psoriasis","volume":"133","author":"Young","year":"2023","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115357_bb0090","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12951-021-00943-z","article-title":"Immunomodulatory nanocarriers for topical therapy in inflammatory skin disorders","volume":"22","author":"Zhu","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.115357_bb0095","article-title":"A triple-targeting \u201cnano-brake\u201d remodeling the impaired immune microenvironment in skin lesions for psoriasis treatment","volume":"32","author":"Chen","year":"2025","journal-title":"Mater. Today Bio"},{"issue":"6","key":"10.1016\/j.jconrel.2026.115357_bb0100","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1039\/D5PM00173K","article-title":"Emerging smart microneedle technologies in psoriasis: convergence of nanocarriers, machine learning, and personalized delivery","volume":"2","author":"Sutar","year":"2025","journal-title":"RSC Pharm."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115357_bb0105","first-page":"4502","article-title":"Immune-modulating nanoparticles for treatment of chronic inflammatory diseases","volume":"19","author":"Zhang","year":"2025","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.jconrel.2026.115357_bb0110","first-page":"379","article-title":"Delivering safer immunotherapies for cancer","volume":"20","author":"Milling","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115357_bb0115","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","article-title":"Delivery technologies for cancer immunotherapy","volume":"18","author":"Riley","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115357_bb0120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41577-018-0084-5","article-title":"The immunological anatomy of the skin","volume":"19","author":"Kabashima","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115357_bb0125","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/bjd\/ljad303","article-title":"Resident cutaneous memory T cells: a clinical review of their role in chronic inflammatory dermatoses and potential as therapeutic targets","volume":"189","author":"Pham","year":"2023","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jconrel.2026.115357_bb0130","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.imlet.2018.06.009","article-title":"Taking the lead \u2014 how keratinocytes orchestrate skin T cell immunity","volume":"200","author":"Klicznik","year":"2018","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jconrel.2026.115357_bb0135","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fimmu.2018.00093","article-title":"Langerhans cells: sensing the environment in health and disease","volume":"9","author":"Deckers","year":"2018","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115357_bb0140","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.4049\/jimmunol.1302313","article-title":"Epidermal Th22 and Tc17 cells form a localized disease memory in clinically healed psoriasis","volume":"192","author":"Cheuk","year":"2014","journal-title":"J. Immunol."},{"issue":"77","key":"10.1016\/j.jconrel.2026.115357_bb0145","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abq3254","article-title":"Local IL-23 is required for proliferation and retention of skin-resident memory Th17 cells","volume":"7","author":"Whitley","year":"2022","journal-title":"Sci. Immunol."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115357_bb0150","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3892\/etm.2022.11124","article-title":"Update on the etiopathogenesis of psoriasis (review)","volume":"23","author":"Branisteanu","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.jconrel.2026.115357_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.104985","article-title":"High-dimensional profiling of regulatory T cells in psoriasis reveals an impaired skin-trafficking property","volume":"100","author":"Lee","year":"2024","journal-title":"EBioMedicine"},{"issue":"5","key":"10.1016\/j.jconrel.2026.115357_bb0160","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nri3646","article-title":"Mechanisms regulating skin immunity and inflammation","volume":"14","author":"Pasparakis","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115357_bb0165","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3390\/ph16020246","article-title":"Neural regulation of innate immunity in inflammatory skin diseases","volume":"16","author":"Huang","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115357_bb0170","doi-asserted-by":"crossref","first-page":"209","DOI":"10.5114\/ada.2021.113125","article-title":"The effect of therapy on TRM in psoriatic lesions","volume":"39","author":"Owczarczyk-Saczonek","year":"2022","journal-title":"Adv. Dermatol. Allergol."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115357_bb0175","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1038\/jid.2011.139","article-title":"Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin","volume":"131","author":"Bovenschen","year":"2011","journal-title":"J. Invest. Dermatol."},{"issue":"21","key":"10.1016\/j.jconrel.2026.115357_bb0180","doi-asserted-by":"crossref","first-page":"8406","DOI":"10.3390\/ijms21218406","article-title":"Molecular and cellular mechanisms of itch in psoriasis","volume":"21","author":"Komiya","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115357_bb0185","series-title":"Psoriasis: Targets and Therapy","first-page":"7","article-title":"Current knowledge on psoriasis and autoimmune diseases","volume":"6","author":"Ayala-Font\u00e1nez","year":"2016"},{"key":"10.1016\/j.jconrel.2026.115357_bb0190","doi-asserted-by":"crossref","DOI":"10.1007\/s12247-025-10177-3","article-title":"Transdermal therapeutics for psoriasis management using minimally invasive approaches","volume":"20","author":"Upadhyay","year":"2025","journal-title":"J. Pharm. Innov."},{"key":"10.1016\/j.jconrel.2026.115357_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1233514","article-title":"Alleviating psoriatic skin inflammation through augmentation of Treg cells via CTLA-4 signaling peptide","volume":"14","author":"Lee","year":"2023","journal-title":"Front. Immunol."},{"issue":"31","key":"10.1016\/j.jconrel.2026.115357_bb0200","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb5274","article-title":"Topical nanoparticles interfering with the DNA-LL37 complex to alleviate psoriatic inflammation in mice and monkeys","volume":"6","author":"Liang","year":"2020","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115357_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.103465","article-title":"Insight into the pivotal role of signaling pathways in psoriasis pathogenesis, potential therapeutic molecules and drug delivery approaches","volume":"28","author":"Tomar","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2026.115357_bb0210","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jconrel.2015.09.017","article-title":"Nucleic acid delivery into skin for the treatment of skin disease: proofs-of-concept, potential impact, and remaining challenges","volume":"219","author":"Zakrewsky","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115357_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.618897","article-title":"Pathophysiology of skin resident memory T cells","volume":"11","author":"Tokura","year":"2021","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115357_bb0220","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s13346-020-00723-6","article-title":"Nanostructured lipid carrier co-delivering tacrolimus and TNF-\u03b1 siRNA as an innovate approach to psoriasis","volume":"10","author":"Viegas","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115357_bb0225","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s13671-019-0248-y","article-title":"Nanotechnology for psoriasis therapy","volume":"8","author":"Murphy","year":"2019","journal-title":"Curr. Derm. Rep."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115357_bb0230","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3390\/pharmaceutics16040449","article-title":"Recent approaches for the topical treatment of psoriasis using nanoparticles","volume":"16","author":"Bodn\u00e1r","year":"2024","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115357_bb0235","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1080\/10717544.2020.1754527","article-title":"Tackling the various classes of nano-therapeutics employed in topical therapy of psoriasis","volume":"27","author":"Fereig","year":"2020","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2026.115357_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122591","article-title":"Microneedles as a momentous platform for psoriasis therapy and diagnosis: a state-of-the-art review","volume":"632","author":"Gowda","year":"2023","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115357_bb0245","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1080\/17425247.2023.2190095","article-title":"Enhanced skin drug delivery using dissolving microneedles: a potential approach for the management of skin disorders","volume":"20","author":"Priya","year":"2023","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2026.115357_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113794","article-title":"Dissolving microneedles in transdermal drug delivery: a critical analysis of limitations and translation challenges","volume":"383","author":"Moawad","year":"2025","journal-title":"J. Control. Release"},{"issue":"12","key":"10.1016\/j.jconrel.2026.115357_bb0255","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1007\/s13346-024-01542-9","article-title":"Cyclosporin A-loaded dissolving microneedles for dermatitis therapy: development, characterisation and efficacy in a delayed-type hypersensitivity in vivo model","volume":"14","author":"Mart\u00ednez-Navarrete","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2026.115357_bb0260","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jconrel.2024.09.032","article-title":"Cyanocobalamin-loaded dissolving microneedles diminish skin inflammation in vivo","volume":"375","author":"Guillot","year":"2024","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.jconrel.2026.115357_bb0265","article-title":"Double-layered polyvinylpyrrolidone\u2013poly(methyl vinyl ether-alt-maleic acid)-based microneedles to deliver meloxicam: an in vitro, in vivo, and short-term stability evaluation study","volume":"6","author":"D\u2019Amico","year":"2023","journal-title":"Adv. Ther."},{"key":"10.1016\/j.jconrel.2026.115357_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.804415","article-title":"Transdermal delivery of therapeutic compounds with nanotechnological approaches in psoriasis","volume":"9","author":"Li","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"27","key":"10.1016\/j.jconrel.2026.115357_bb0275","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202401384","article-title":"Nanotechnology-mediated immunomodulation strategy for inflammation resolution","volume":"13","author":"Li","year":"2024","journal-title":"Adv. Healthc. Mater."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115357_bb0280","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.7150\/thno.69999","article-title":"Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment","volume":"12","author":"Qu","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.115357_bb0285","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.actbio.2025.05.067","article-title":"CD4+ T cell membrane-based nanocomposites for enhanced dual epigenetic therapy in psoriasis","volume":"201","author":"Hou","year":"2025","journal-title":"Acta Biomater."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115357_bb0290","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1080\/17435889.2025.2506347","article-title":"A drug delivery perspective on nanotechnology-based topical therapeutics for inflammatory skin diseases","volume":"20","author":"Filippo","year":"2025","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.115357_bb0295","article-title":"PF14-mRNA nanoparticles enable safe mRNA-based therapeutics for inflammatory skin conditions","volume":"14","author":"Periyasamy","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115357_bb0300","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.2147\/IJN.S441353","article-title":"Topical delivery of microRNA-125b by framework nucleic acids for psoriasis treatment","volume":"19","author":"Han","year":"2024","journal-title":"Int. J. Nanomedicine"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115357_bb0305","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.apsb.2020.11.008","article-title":"Uptake and trafficking of different sized PLGA nanoparticles by dendritic cells in imiquimod-induced psoriasis-like mice model","volume":"11","author":"Lin","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115357_bb0310","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.apsb.2021.07.019","article-title":"Enhanced uptake and anti-maturation effect of celastrol-loaded mannosylated liposomes on dendritic cells for psoriasis treatment","volume":"12","author":"Xi","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"10","key":"10.1016\/j.jconrel.2026.115357_bb0315","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12361","article-title":"Plant exosomes fused with engineered mesenchymal stem cell-derived nanovesicles for synergistic therapy of autoimmune skin disorders","volume":"12","author":"Huang","year":"2023","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.jconrel.2026.115357_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2024.08.037","article-title":"Stimuli-responsive drug delivery systems for inflammatory skin conditions","volume":"187","author":"Gade","year":"2024","journal-title":"Acta Biomater."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115357_bb0325","doi-asserted-by":"crossref","DOI":"10.1002\/VIW.20240043","article-title":"Cell membrane and extracellular vesicle membrane-coated nanoparticles: an envisaged approach for the management of skin conditions","volume":"5","author":"Mac\u00e1rio-Soares","year":"2024","journal-title":"VIEW"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115357_bb0330","doi-asserted-by":"crossref","first-page":"5726","DOI":"10.1038\/s41467-021-26052-x","article-title":"Cell membrane coating integrity affects the internalization mechanism of biomimetic nanoparticles","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.jconrel.2026.115357_bb0335","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1021\/acs.molpharmaceut.5c00056","article-title":"Roadmap for commercial nanomedicine development: integrating quality by design principles with pharmaceutical nanotechnology","volume":"22","author":"Maheshwari","year":"2025","journal-title":"Mol. Pharm."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115357_bb0340","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3390\/pharmaceutics17070888","article-title":"Nanotechnology approaches for mitigating biologic immunogenicity: a literature review","volume":"17","author":"Alanazi","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115357_bb0345","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.bbi.2024.10.031","article-title":"An initial investigation of transcutaneous delivery of plasmid DNA encoding interleukin-10 for the treatment of psoriatic skin conditions","volume":"123","author":"Rocha","year":"2025","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jconrel.2026.115357_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2024.148903","article-title":"Genome-wide RNA-seq, DNA methylation and small RNA-seq analysis unraveled complex gene regulatory networks in psoriasis pathogenesis","volume":"933","author":"Laha","year":"2025","journal-title":"Gene"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115357_bb0355","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3390\/biomedicines13040781","article-title":"Novel small-molecule treatment and emerging biological therapy for psoriasis","volume":"13","author":"Li","year":"2025","journal-title":"Biomedicines"},{"issue":"11","key":"10.1016\/j.jconrel.2026.115357_bb0360","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3390\/ph13110360","article-title":"Gene regulation using spherical nucleic acids to treat skin disorders","volume":"13","author":"Holmes","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jconrel.2026.115357_bb0365","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.2147\/IJN.S504639","article-title":"Using siRNA-based anti-inflammatory lipid nanoparticles for gene regulation in psoriasis","volume":"20","author":"Zeng","year":"2025","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.115357_bb0370","doi-asserted-by":"crossref","first-page":"7631","DOI":"10.2147\/IJN.S461514","article-title":"Recent advancements and trends of topical drug delivery systems in psoriasis: a review and bibliometric analysis","volume":"19","author":"An","year":"2024","journal-title":"Int. J. Nanomedicine"},{"issue":"14","key":"10.1016\/j.jconrel.2026.115357_bb0375","doi-asserted-by":"crossref","first-page":"7311","DOI":"10.3390\/ijms22147311","article-title":"Molecular mechanisms of ZC3H12C\/Reg-3 biological activity and its involvement in psoriasis pathology","volume":"22","author":"Wawro","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"33","key":"10.1016\/j.jconrel.2026.115357_bb0380","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202303706","article-title":"Transcutaneous immunotherapy for RNAi: a cascade-responsive decomposable nanocomplex based on polyphenol-mediated framework nucleic acid in psoriasis","volume":"10","author":"Zhang","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.115357_bb0385","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2024.1342178","article-title":"Structure-activity relationship study of mesyl and busyl phosphoramidate antisense oligonucleotides for unaided and PSMA-mediated uptake into prostate cancer cells","volume":"12","author":"Sergeeva","year":"2024","journal-title":"Front. Chem."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115357_bb0390","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.202300366","article-title":"Recent progress in the endosomal escape mechanism and chemical structures of polycations for nucleic acid delivery","volume":"24","author":"Mehta","year":"2024","journal-title":"Macromol. Biosci."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115357_bb0395","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1039\/D5MD00084J","article-title":"In vivo demonstration of enhanced mRNA delivery by cyclic disulfide-containing lipid nanoparticles for facilitating endosomal escape","volume":"16","author":"Kimura","year":"2025","journal-title":"RSC Med. Chem."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115357_bb0400","first-page":"5765","article-title":"Structure-guided design of endosomolytic chloroquine-like lipid nanoparticles for mRNA delivery and genome editing","volume":"16","author":"Liu","year":"2025","journal-title":"Nat. Commun."},{"issue":"16","key":"10.1016\/j.jconrel.2026.115357_bb0405","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adl4336","article-title":"Dual-responsive nanocarriers for efficient cytosolic protein delivery and CRISPR-Cas9 gene therapy of inflammatory skin disorders","volume":"10","author":"Tan","year":"2024","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115357_bb0410","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.70213","article-title":"Interface-engineered nanocarriers for translational and patient-centric topical therapy in psoriasis","volume":"87","author":"Singh","year":"2025","journal-title":"Drug Dev. Res."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115357_bb0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.33140\/IJNN.10.01.01","article-title":"Advances in nanocarrier systems for dermatologic transdermal drug delivery: a chemical and molecular review","volume":"1","author":"Parga","year":"2025","journal-title":"Int. J. Nanotechnol. Nanomed."},{"key":"10.1016\/j.jconrel.2026.115357_bb0420","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.791725","article-title":"Chimerism-based tolerance to kidney allografts in humans: novel insights and future perspectives","volume":"12","author":"Podest\u00e0","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115357_bb0425","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fimmu.2019.00043","article-title":"Past, present, and future of regulatory T cell therapy in transplantation and autoimmunity","volume":"10","author":"Romano","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115357_bb0430","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.3389\/fimmu.2019.02668","article-title":"Mechanisms of post-transplantation cyclophosphamide: an evolving understanding","volume":"10","author":"Schneider","year":"2019","journal-title":"Front. Immunol."},{"issue":"34","key":"10.1016\/j.jconrel.2026.115357_bb0435","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202307485","article-title":"Microneedle patch for transdermal sequential delivery of KGF-2 and aFGF to enhance burn wound therapy","volume":"20","author":"He","year":"2024","journal-title":"Small"},{"issue":"11","key":"10.1016\/j.jconrel.2026.115357_bb0440","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1016\/j.apsb.2024.06.014","article-title":"Spatiotemporally responsive cascade bilayer microneedles integrating local glucose depletion and sustained nitric oxide release for accelerated diabetic wound healing","volume":"14","author":"Zeng","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115357_bb0445","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12951-021-00800-z","article-title":"A paclitaxel and microRNA-124 coloaded stepped cleavable nanosystem against triple negative breast cancer","volume":"19","author":"Chen","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.115357_bb0450","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jconrel.2024.11.056","article-title":"White paper: understanding, informing and defining the regulatory science of microneedle-based dosage forms that are applied to the skin","volume":"378","author":"Dul","year":"2024","journal-title":"J. Control. Release"},{"issue":"14","key":"10.1016\/j.jconrel.2026.115357_bb0455","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.2217\/nnm.13.202","article-title":"Topical administration of dual siRNAs using fusogenic lipid nanoparticles for treating psoriatic-like plaques","volume":"9","author":"Marepally","year":"2014","journal-title":"Nanomedicine"},{"issue":"8","key":"10.1016\/j.jconrel.2026.115357_bb0460","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/j.jid.2020.12.034","article-title":"CCR4 involvement in the expansion of T helper type 17 cells in a mouse model of psoriasis","volume":"141","author":"Matsuo","year":"2021","journal-title":"J. Invest. Dermatol."},{"issue":"83","key":"10.1016\/j.jconrel.2026.115357_bb0465","article-title":"Tissue-resident memory T cell maintenance during antigen persistence requires both cognate antigen and interleukin-15","volume":"8","author":"Tieu","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.jconrel.2026.115357_bb0470","doi-asserted-by":"crossref","DOI":"10.1136\/ard-2023-225069","article-title":"CD8+ tissue-resident memory T cells are expanded in primary Sj\u00f6gren\u2019s disease and can be therapeutically targeted by CD103 blockade","author":"Mauro","year":"2024","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115357_bb0475","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/j.jid.2017.04.027","article-title":"Topically delivered tumor necrosis factor-\u03b1\u2013targeted gene regulation for psoriasis","volume":"137","author":"Lewandowski","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jconrel.2026.115357_bb0480","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jconrel.2021.08.039","article-title":"TNF\u03b1 siRNA delivery by nanoparticles and photochemical internalization for psoriasis topical therapy","volume":"338","author":"Suzuki","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115357_bb0485","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jconrel.2022.05.032","article-title":"Laser-assisted nanocarrier delivery to achieve cutaneous siRNA targeting for attenuating psoriasiform dermatitis","volume":"347","author":"Lee","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115357_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123019","article-title":"Liquid crystalline nanoparticles enable a multifunctional approach for topical psoriasis therapy by co-delivering triptolide and siRNAs","volume":"640","author":"Silvestrini","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115357_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113581","article-title":"Dendritic lipopeptide-based transdermal siRNA delivery systems for effective non-invasive therapy in psoriasis","volume":"381","author":"Ma","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115357_bb0500","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jconrel.2023.10.035","article-title":"Disease-specific corona mediated co-delivery of MTX and siRNA-TNF\u03b1 by a polypeptide nanoplatform with antigen-scavenging functions in psoriasis","volume":"364","author":"Xin","year":"2023","journal-title":"J. Control. Release"},{"issue":"9","key":"10.1016\/j.jconrel.2026.115357_bb0505","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1007\/s13346-025-01800-4","article-title":"Topical delivery of siRNA to psoriatic skin model using high molecular weight chitosan derivatives: in vitro and in vivo studies","volume":"15","author":"Martinez","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"issue":"18","key":"10.1016\/j.jconrel.2026.115357_bb0510","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22189797","article-title":"Umbilical cord blood mononuclear cell-derived small extracellular vesicles modulate immune responses in 3D psoriatic skin and reduce inflammation","volume":"22","author":"Rodrigues","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115357_bb0515","article-title":"De-escalating and discontinuing disease-modifying therapies in multiple sclerosis: an ECTRIMS workshop report","author":"Androdias","year":"2024","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115357_bb0520","doi-asserted-by":"crossref","first-page":"adv00034","DOI":"10.2340\/00015555-3388","article-title":"Pustular psoriasis: the dawn of a new era","volume":"100","author":"Bachelez","year":"2020","journal-title":"Acta Derm. Venereol."},{"issue":"16","key":"10.1016\/j.jconrel.2026.115357_bb0525","doi-asserted-by":"crossref","first-page":"9048","DOI":"10.3390\/ijms22169048","article-title":"Generalized pustular psoriasis: divergence of innate and adaptive immunity","volume":"22","author":"Samotij","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.jconrel.2026.115357_bb0530","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/exd.14768","article-title":"Pathophysiology of generalized pustular psoriasis","volume":"32","author":"Young","year":"2023","journal-title":"Exp. Dermatol."},{"issue":"18","key":"10.1016\/j.jconrel.2026.115357_bb0535","article-title":"Th17 cells with regulatory phenotype are the main IL-17F and IL-26 producers in palmoplantar pustulosis","volume":"10","author":"Tran","year":"2025","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.jconrel.2026.115357_bb0540","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/bjd\/ljad283","article-title":"Integrative serum proteomics analysis reveals distinct immune and cardiovascular profile dysregulation in erythrodermic psoriasis","volume":"189","author":"Song","year":"2023","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115357_bb0545","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/cup.14775","article-title":"Cytokine profiling of erythroderma biopsies reveals types 2 and 17 immune activation status","volume":"52","author":"Pukhalskaya","year":"2024","journal-title":"J. Cutan. Pathol."},{"key":"10.1016\/j.jconrel.2026.115357_bb0550","first-page":"36","article-title":"A case series of early biologic therapy in guttate psoriasis: targeting resident memory T cell activity as a potential novel therapeutic modality","volume":"25","author":"Flora","year":"2022","journal-title":"JAAD Case Rep."},{"key":"10.1016\/j.jconrel.2026.115357_bb0555","doi-asserted-by":"crossref","DOI":"10.7573\/dic.2023-8-2","article-title":"Childhood guttate psoriasis: an updated review","volume":"12","author":"Leung","year":"2023","journal-title":"Drugs Context"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115357_bb0560","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/1346-8138.17415","article-title":"HLA-C*06:02 in Danish patients with psoriasis and response to biological treatment","volume":"52","author":"Bergmann","year":"2024","journal-title":"J. Dermatol."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115357_bb0565","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/bjd\/ljad481","article-title":"The association of age at psoriasis onset and HLA-C*06:02 with biologic survival in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)","volume":"190","author":"Alabas","year":"2023","journal-title":"Br. J. Dermatol."},{"issue":"29","key":"10.1016\/j.jconrel.2026.115357_bb0570","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202502315","article-title":"Nanoparticle therapeutics in clinical perspective: classification, marketed products, and regulatory landscape","volume":"21","author":"Desai","year":"2025","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115357_bb0575","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1186\/s12951-024-02901-x","article-title":"Nanotechnology in healthcare, and its safety and environmental risks","volume":"22","author":"Ma","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"15","key":"10.1016\/j.jconrel.2026.115357_bb0580","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1080\/17435889.2025.2533107","article-title":"Regulating nanomedicines: challenges, opportunities, and the path forward","volume":"20","author":"Mangla","year":"2025","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.115357_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2022.104118","article-title":"Current regulatory landscape of nanomaterials and nanomedicines: a global perspective","volume":"80","author":"Ali","year":"2023","journal-title":"J. Drug Delivery Sci. Technol."},{"issue":"20","key":"10.1016\/j.jconrel.2026.115357_bb0590","article-title":"Feeding next-generation nanomedicines to Europe: regulatory and quality challenges","volume":"12","author":"Musazzi","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.115357_bb0595","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1544393","article-title":"Regulatory pathways and guidelines for nanotechnology-enabled health products: a comparative review of EU and US frameworks","volume":"12","author":"Rodr\u00edguez-G\u00f3mez","year":"2025","journal-title":"Front. Med."},{"key":"10.1016\/j.jconrel.2026.115357_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114236","article-title":"Regulatory guidelines and preclinical tools to study the biodistribution of RNA therapeutics","volume":"184","author":"Vervaeke","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115357_bb0605","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12951-025-03113-7","article-title":"A systematic review of nanocarriers used in medicine and beyond: definition and categorization framework","volume":"23","author":"Gressler","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.115357_bb0610","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.1012497","article-title":"RNA-based drugs and regulation: toward a necessary evolution of the definitions issued from the European Union legislation","volume":"9","author":"Guerriaud","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.jconrel.2026.115357_bb0615","series-title":"Nanocarriers for Drug Delivery","author":"Eloy","year":"2021"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115357_bb0620","doi-asserted-by":"crossref","first-page":"8539","DOI":"10.1038\/s41598-022-12100-z","article-title":"DoE-derived continuous and robust process for manufacturing of pharmaceutical-grade wide-range LNPs for RNA-vaccine\/drug delivery","volume":"12","author":"Nag","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.115357_bb0625","author":"U.S. Food and Drug Administration (FDA)"},{"key":"10.1016\/j.jconrel.2026.115357_bb0630","author":"European Medicines Agency (EMA)"},{"issue":"19","key":"10.1016\/j.jconrel.2026.115357_bb0635","doi-asserted-by":"crossref","first-page":"8948","DOI":"10.3390\/app14198948","article-title":"Nanostructured drug delivery systems in immunotherapy: An updated overview of nanotechnology-based therapeutic innovations","volume":"14","author":"Croitoru","year":"2024","journal-title":"Appl. Sci."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115357_bb0640","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.3390\/ijms22094983","article-title":"Psoriasis: from pathogenesis to pharmacological and nano-technological-based therapeutics","volume":"22","author":"Petit","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115357_bb0645","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/jfb14010019","article-title":"Nanoscale topical pharmacotherapy in management of psoriasis: contemporary research and scope","volume":"14","author":"Ahmad","year":"2022","journal-title":"J. Funct. Biomater."},{"issue":"6527","key":"10.1016\/j.jconrel.2026.115357_bb0650","doi-asserted-by":"crossref","DOI":"10.1126\/science.aba6500","article-title":"Developmental cell programs are co-opted in inflammatory skin disease","volume":"371","author":"Reynolds","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115357_bb0655","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1340677","article-title":"Immune cells in the epithelial immune microenvironment of psoriasis: emerging therapeutic targets","volume":"14","author":"Li","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115357_bb0660","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s13346-022-01262-y","article-title":"Nanomedicines and nanocarriers in clinical trials: surfing through regulatory requirements and physicochemical critical quality attributes","volume":"13","author":"Dri","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2026.115357_bb0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114395","article-title":"Toward intelligent immune microneedles: strategies for sensing, therapy, and immune regulation","volume":"388","author":"Ge","year":"2025","journal-title":"J. Control. Release"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926007613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926007613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T09:49:56Z","timestamp":1793440196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926007613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":133,"alternative-id":["S0168365926007613"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115357","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A design framework for skin-targeted RNA nanomedicines: spatial reprogramming of immune memory in psoriasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115357","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115357"}}